Revenue (MTD)
$128,400
+3.5% vs. budget
Gross Margin
56.2%
+1.1 pts vs. target
EBITDA
$19,200
15.0% margin
Cash Position
$312,500
15.8 weeks runway
Cash Balance & Monthly Flows
Variance Highlights
Revenue came in 3.5% ahead of budget on stronger project receipts, while gross margin held above target despite a tax payment landing a month earlier than planned. Cash position remains healthy, with runway above 15 weeks.
Utilization (Blended)
71%
4 pts below 75% target
AR Past Due
$58,000
1 client, 4 days past terms
Rate Realization
95.4%
No rate gaps flagged
Utilization by Department
AR Aging Summary
| Client | Balance | Days Out | Terms | Status |
|---|
Revenue: Prior Year, Budget & Actual / Pipeline (Jan–May 2026)
New Business Pipeline
| Opportunity | Stage | Start | End | Probability | Value | CY Value |
|---|
Scenario: Revenue Change
Revised Revenue
$128,400
Revised EBITDA
$19,200
EBITDA Margin
15.0%
March 2026 CFO Memo
Revenue closed 3.5% ahead of budget, driven primarily by project receipts landing earlier than scheduled on the Novara Health identity project. Gross margin held at 56.2%, slightly above target, even with an early quarterly tax payment.
Utilization came in at 71%, four points below the 75% target. The gap is concentrated in the creative department, where bench time increased following the wrap of the Fenwick Studios motion project. Worth watching over the next month to confirm this is a timing issue rather than a pipeline gap.
Cash position remains healthy at $312,500, with runway above 15 weeks. One AR item, Fenwick Studios at $58,000, is now past 60 days and should move to active follow up.
Memo History